Venous thrombosis and occult cancer;Trombosis venosa y cáncer oculto

Angiologia

Volumn 53, Issue 1-6, 2001, Pages 301-309

  Garcia Gimeno M ^a   Alonso Alvarez M ^a   Gonzalez Fueyo M J ^a   Malo Benajes, E ^a   Fernandez Moran M C ^a   Ortega Martin, J M ^a   Fernandez Samos Gutierrez R ^a   Garcia Vazquez J ^a   Zorita Calvo, A ^a   Vaquero Morillo, Fernando ^a,b  

^a HOSPITAL DE LEÓN   (Spain)

^b NONE   (Spain)

Author keywords

Deep vein thrombosis; Occult cancer

Indexed keywords

EID: 0346526152     PISSN: 00033170     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-3170(01)74704-9     Document Type: Article

References (23)

1. Trousseau A. Phlegmasia alba dolens. Clinique Médicale de l'Hotel Dieu de Paris. The New Syndeham Society (London) 1865; 3: 94-8.
2. Sproul E. Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer 1938; 34: 566-75.
3. Aderka D, Brown A, Zelikovski A, Pinkhas J. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sing of occult cancer. Cancer 1986; 57: 1846-9.
4. Monreal M, Salvador S, Soriano V, Sabria M. Cancer and deep venous thrombosis. Arch Intern Med 1988; 148: 485-90.
5. Griffin MR, Stamsom A, Brown M, Hauser A, O'Fallon W, Anderson H, et al. Deep venous thrombosis and pulmonary embolism: risk of subsequent malignant neoplasms. Arch Intern Med 1987; 147: 1907-11.
6. Levine M. The diagnosis and treatment of thrombosis in the cancer patient. Semin Oncol 1990; 17: 160-71.
7. Viale PH. Management of thromboembolism in patients with cancer. Oncol Nurs Forum 1999; 26: 1625-9.
8. Johnson MJ, Sproule MW, Paul J. The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer. Clin Oncol (R Coll Radiol) 1999; 11: 105-10.
9. Valente M, Ponte E. Thrombosis and cancer. Minerva Cardioangiol 2000; 48: 117-27.
10. Kakkar AK, De Lorenzo F, Pineo GF, Williamson RC. Venous thromboembolism and cancer. Baillieres Clin Haematol 1998; 11: 675-87.
11. Rickles FR, Levine MN. Venous thromboembolism in malignancy and malignancy in venous thromboembolism. Haemostasis 1998; 28 (Suppl 3): 43-9.
12. Monreal M, Prandoni P. Venous thromboembolism as first manifestation of cancer. Semin Thromb Hemost 1999; 25: 31-6.
13. Levitan N, Dowlati A, Resmick SC, Tahsildar HI, Sivinski LD, Beyth R, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 1999; 78: 285-91.
14. Prandoni P, Piccioli A, Girolami A. Cancer and venous thromboembolism: an overview. Haematologica 1999; 84: 437-45.
15. Vaquero F. Tumor y patologia venosa. In Cairols MA, ed. Temas actuales en angiología y cirugía vascular. Barcelona: Espaxs; 1993. p. 417-36.
16. Subirá M, Mateo J, Souto JC, Altés A, Fontcuberta J. Lack of association between venous thrombosis and subsequent malignancy in a retrospective cohort study in young patients. Am J Hematol 1999; 60: 181-4.
17. Haimovici H. Ischemic venous thrombosis: phlegmasia cerulea dolens and venous gangrena. Haimovici's vascular surgery principles and techniques. Cambridge (Massachusetts): Blabkwell-Science; 1996. p. 1267-81.
18. Yang MH, Fan FS, Chen PM, Liu JH, Chiou TS, Wang WS, et al. Venous gangrene in a patient with adenocarcinoma of the lung. Jpn J Clin Oncol 2000; 30: 276-8.
19. Kimura T, Chino M, Ogasawara N, Nakano T, Izumi S, Takeuchi H. Trousseau's syndrome with brachiocephalic vein thrombosis in a patient with uterine carcinosarcoma. A case report. Angiology 1999; 50: 515-8.
20. Smorenburg SM, Hutten BA, Prins MH. Should patients with venous thromboembolism and cancer be treated differently? Haemostasis 1999; 29 (Suppl 1): 91-7.
21. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000; 18: 3078-83.
22. Bona RD, Hickey AD, Wallace DM. Warfarin is safe as secondary prophylaxis in patients with cancer and previous episode of venous thrombosis. Am J Clin Oncol 2000; 23: 71-3.
23. Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 2000; 89: 640-6.